|
인쇄하기
취소
|
Multinational firm to be under siege in antitrust debate
Published: 2009-11-02 07:00:00
Updated: 2009-11-02 07:00:00
Multinational drug manufacturers will face the health ministry’s scrutiny for their monopolistic behaviors with Zuellig Pharma Korea (ZPK).
The Ministry of Health, Welfare and Family Affairs said it had consecutive meetings with representative from Pfizer Korea on October 28 to discuss ZPK’s monopolistic status on October 28, following its previous meeting with Dongwon Pharma Group on the sa...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.